Lauren Miller Rogen
Showing 1–2 of 2 transcripts.
- Milken Institute57 min
From Experience to Excellence: Women Redefining Business and Financial Wellness | Global Conference
Sheryl WuDunn, Sheila Marcelo, Lauren Miller Rogen, Penny Pennington, Michele Trogni, Michelle Choney
This panel convened financial leaders, health innovators, and care advocates to address systemic failures in institutions designed around male lifespans, highlighting that women over 45 now launch businesses at twice the rate of men despite facing significantly higher chronic illness rates and lower retirement savings. Through initiatives by Zinnia, Edward Jones, Hilarity for Charity, and Ojai.ai, the discussion proposed a holistic framework integrating financial longevity, AI-driven household management, and brain health education to transition from "work-life balance" to comprehensive power. The resulting strategy advocates for redesigned risk profiles, early protective insurance planning, and intergenerational conversations to secure the $10 trillion in assets currently held by women against the projected demographic shifts in caregiving and wealth transfer.
- Milken Institute1h 5m
Alzheimer's Disease: Rewriting the Playbook
LaTese Briggs, Michela Gallagher, Todd Rainwater, Lauren Miller Rogen, Garen Staglin, Garen King Jr., Daniel Arbus, Elizabeth Scharf, Amir, Mark Reuthmeyer
Leading scientists and philanthropists convened to address the projected surge in Alzheimer's prevalence and its looming $1.1 trillion economic impact by 2050, shifting research focus from the failed amyloid hypothesis to tau-targeted interventions and early prodromal treatment. The panel highlighted strategic initiatives such as the TAO Consortium's $100 million investment in tauopathies, the proposed $10 billion global social impact bond, and new collaborative models designed to accelerate FDA approval through consortium-based data sharing. By combining precision medicine, open science, and stigma-reduction advocacy, these stakeholders aim to de-risk early-stage development and attract pharmaceutical investment to prevent a global health crisis.